Category Archives: News from QED Bioscience

A novel signaling pathway in which Heat Shock Protein 70 (Hsp70) plays a role has been added to its many […]

A very interesting study conducted at the University of Tübingen, Germany revealed that a compound produced by nasal Staphylococcus lugdunensis […]

Group B Streptococci are bacteria linked to preterm birth and newborn infections.  A recent article in The Scientist summarized research conducted […]

A recent independent study conducted by Antibody Resource demonstrated outstanding performance of QED Bioscience’s ubiquitin monoclonal antibody (catalog no. 11023) when […]

Did you know that QED Bioscience offers 2 excellent antibodies to human Fibronectin that can inhibit cell adhesion? They are our catalog nos. 42040 and 42042.

The role of the gene Nitrilase 1 (Nit1) in the proliferation of cancer cells is elucidated in this article. Focus […]

BioTechniques March 1, 2016 This article looks at molecular mimicry as a basis for development of antiphospholipid syndrome (APS), an […]

QED Bioscience has introduced an extensive selection of highly specific and well-characterized antibodies to phosphorylated amino acids of proteins that […]

Does your therapeutic antibody program require Anti-Id antibodies to evaluate biodistribution, clearance, or immunogenicity? Call us – we’ll gladly discuss […]

Did you know that QED Bioscience is the original manufacturer of dozens of Therapeutic Drug Monitoring (TDM) monoclonal antibodies?  We […]